Click Therapeutics, a developer of AI-based digital therapeutics, raised $50 million in Series D funding from Boehringer Ingelheim, to support the commercialization of its CT-155, an investigational prescription digital therapeutic that is being studied for the treatment of the experiential negative symptoms of schizophrenia in adults aged 18 years and older.
“Boehringer Ingelheim’s selection of Click to deliver CT-155 to patients is powerful validation of our vision and the capabilities we have spent over a decade building,” said David Benshoof Klein, CEO and founder of Click Therapeutics.
“We are eager to take the lead with CT-155 and are focused on getting this FDA-designated Breakthrough Device to patients after clearance by the FDA,” added David Benshoof Klein.
Click Therapeutics develops regulated, clinically validated prescription mobile applications to address diverse therapeutic needs, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases.
With fresh funds, the company will accelerate the commercialization of its software as prescription medical treatments for people with unmet medical needs. Operating at the intersection of biology and technology, Click uses a proprietary platform-based approach to therapeutic development that leverages patient-centric design principles and innovative AI-based technologies to deliver a unique combination of engagement and clinical outcomes.
Digital health companies, including digital therapeutics, have secured more than $180 billion in funding to date, according to our recent Funding Database.
Notable recent digital health funding rounds include:
- Ethermed, a healthcare technology startup building AI-driven automation for prior authorization and medical-necessity workflows, raised $8.5 million in Series A funding to expand its enterprise platform and scale its growing network of health-system partners.
- Worki, a San Francisco-based healthcare workforce productivity visibility startup, raised $2.75 million in pre-seed funding led by Redesign Health and Healthliant Ventures, the venture arm of Tanner Health.
- Joyful Health, a provider of AI financial infrastructure for healthcare revenue operations, raised $17 million in Series A funding to build a financial operating system for healthcare providers.
- Luminai, a provider of an AI-powered healthcare workflow automation platform, raised $38 million in a Series B funding round, bringing its total funding to date to $60 million.
- Keebler Health, a clinical documentation startup, raised $16 million in a Series A funding round to accelerate commercial growth in the US. Including the Series A round, Keebler Health has raised $23 million to date.